Comparison

MK-677 vs Ipamorelin: Evidence-Based Comparison

Compare MK-677 and Ipamorelin: dosing, mechanisms, safety profiles, and research evidence. Citation-backed comparison.

Overview

A comparison of MK-677 and Ipamorelin as growth hormone secretagogues, covering oral vs. injectable administration, half-life, GH pulse patterns, and research contexts.

Compared compounds

MK-677 Ipamorelin

Overview

MK-677 and Ipamorelin are both ghrelin receptor agonists studied for growth hormone secretagogue effects, but they differ substantially in administration route, half-life, and GH pulse pattern. MK-677 is an orally active small molecule, while Ipamorelin is a peptide requiring subcutaneous injection, and these differences define most protocol comparisons between them.

Mechanism Comparison

Both compounds act through the GHSR-1a receptor to stimulate GH release. MK-677 is noted for its long half-life (approximately 24 hours), which produces a sustained elevation in GH and IGF-1 levels rather than discrete pulses. Ipamorelin has a shorter half-life (~2 hours) and is more typically discussed in pulsatile dosing protocols intended to mimic natural GH release timing.

Dosing and Protocol Comparison

MK-677 is typically studied at once-daily oral doses of 10–25 mg, making compliance straightforward. Ipamorelin requires multiple daily injections for pulsatile protocols, often paired with CJC-1295 to amplify the GH signal. Researchers comparing the two often frame MK-677 as more convenient but less controllable, and Ipamorelin as more precise in pulse timing but more demanding in administration frequency.

Evidence Comparison

MK-677 has a meaningful published clinical evidence base including long-duration studies in older adults and GH-deficient populations. Ipamorelin's evidence base is thinner in human studies but well-characterized at the receptor selectivity level. For research purposes, MK-677 offers more published data; Ipamorelin offers more protocol flexibility and selectivity advantage.

Frequently asked questions

Which is better, MK-677 or Ipamorelin?

MK-677 and Ipamorelin are researched for different contexts, so the better choice depends on study goals, mechanism priorities, and protocol design.

Can you stack MK-677 and Ipamorelin?

Some researchers evaluate MK-677 and Ipamorelin together, but combination design depends on evidence quality, safety considerations, and whether overlapping mechanisms are appropriate for the research question.